This joint public meeting was hosted by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) on October 21, 2024. The meeting was intended to address the need for novel smoking cessation products to help individuals of all ages, including underserved and vulnerable populations, stop smoking. The overall goal of the meeting was to stimulate novel product development to reduce rates of smoking and related chronic illnesses. The meeting format included presentations and panel discussions.

Advancing Smoking Cessation: FDA and NIH Priorities [uLf89OqS4]

This joint public meeting was hosted by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) on October 21, 2024. The meeting was intended to address the need for novel smoking cessation products to help individuals of all ages, including underserved and vulnerable populations, stop smoking. The overall goal of the meeting was to stimulate novel product development to reduce rates of smoking and related chronic illnesses. The meeting format included presentations and panel discussions.